Skip to main content
Log in

Pharmacokinetics of oral acetyl-L-carnitine in renal impairment

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Acetyl-L-carnitine 1.5 g and 3.0 g was administered as three divided doses on each of two occasions to 24 people with varying renal failure (creatinine clearance 127 – 8 ml·min−1). Plasma and urinary concentrations of total-L-carnitine, free (non-esterified) carnitine, short-chain esters and acetyl-L-carnitine were measured.

The baseline (pre-study) concentrations of all four substances were related to renal function. Patients whose creatinine clearance was below about 30–40 ml·min−1 were had the highest concentrations.

Renal elimination of all four substances was related to dose and to renal function. There was evidence for dose-related elimination, with greater elimination of the larger dose.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Fabbrini G, Martucci N, Valentini GL, Calvani M, Agnoli A (1988) Correlation between SPECT, NMR imaging and neuropsychological assessment in Alzheimer type dementia and multi-infarct dementia. Senile dementias. Il International Symposium. Agnoli A, Cahn J, Lassen N, Moyeux R (eds) John Libbey Eurotext, Paris, p 247

    Google Scholar 

  2. Bassi S, Ferrarese C, Finoia MG, Frattola L, Iannuccelli M, Meregalli S, Piolti R (1988) L-acetyl-carnitine in Alzheimer disease (AD) and senile dementia Alzheimer type (SDAT). Senile dementias. Il International Symposium. Agnoli A, Cahn J, Lassen N, Moyeux R (eds) John Libbey Eurotext, Paris, p 461

    Google Scholar 

  3. Hiersemenzel R, Dietrich B, Herrmann WM (1988) Therapeutics and EEG — effects of acetyl-L-carnitine in elderly outpatients with mild to moderate cognitive decline. Results of two double-blind placebo-controlled studies. Senile dementias. Il International Symposium. Agnoli A, Cahn J, Lassen N, Moyeux R (eds) John Libbey Eurotext, Paris, p 427

    Google Scholar 

  4. Onofrj M, Bodis-Wollner I, Pola P, Calvani M (1983) Central cholinergic effects of levo-acetylcarnitine. Drugs Exp Clin Res 9: 161–169

    Google Scholar 

  5. Cederblad G, Lindsted S (1972) A method for the determination of carnitine in the picomol range. Clin Chim Acta 37: 235–243

    Google Scholar 

  6. Denis J, McGarry JD, Foster DW (1976) An improved and simplified radioisotope assay for the determination of free and esterified carnitine. J Lipid Res 17: 277–281

    Google Scholar 

  7. Pande SV, Caramcion MN (1981) A simple radioisotopic assay of acetylcarnitine and acetyl-CoA at picomolar levels. Amol Biochem 112: 30–38

    Google Scholar 

  8. Marzo A, Arrigoni-Martelli E, Urso R, Rocchetti M, Rizza V, Kelly JG Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers. Eur J Clin Pharmacol 37: 59–63

  9. Engel AG, Rebouche CJ, Wilson DM, Glasgow AM, Romshe CA, Crase RP (1981) Primary systemic carnitine deficiency: 11. Renal handling of carnitine. Neurology 31: 819–825

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kelly, J.G., Hunt, S., Doyle, G.D. et al. Pharmacokinetics of oral acetyl-L-carnitine in renal impairment. Eur J Clin Pharmacol 38, 309–312 (1990). https://doi.org/10.1007/BF00315038

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00315038

Key words

Navigation